newsfilter
← Latest News
GlobeNewswire·

Supernus to Participate in the 2025 Jefferies Global Healthcare Conference in London

ROCKVILLE, Md., Nov. 12, 2025 (GLOBE NEWSWIRE) -- Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN), a biopharmaceutical company focused on developing and commercializing products for the treatment of central nervous system